Products

Annual Reports AI

AI-native

Decode any business in minutes — not weeks

annualreportai.live Finance / Financial Data & Research

AI Benchmark
Desktop
Mobile
Monthly visits
<5K
Oct 2026
Public revenue
Undisclosed
No public revenue evidence yet
Entry price
Unknown
Subscription model, plan pricing not identified yet
Creators
krishna k
No social account linked
Launched
13d ago
2026-11-06 · Est.

Traffic

Last 12 months
Monthly visitsData through Oct 2026
Events1 marketing move

Marketing moves

Launches, search & content, referrals, promotions
  • Launched on Product HuntLaunch

    AI Stock & Fundamental Analysis

    Nov 6 · 13d agoLaunch page

    At the time: <5K visits/mo

Traffic sources

Oct 2026

Traffic breakdown

Channels

No data yet

Countries

No data yet

Search

Domain authority —Domain registered 2026-06-09

KeywordMonthly volume
equinix investor relations500
mphasis ltd annual report100

Traffic data: Vaneform

Pricing

Top-up packs
Unknown
5 extra reports · valid while your plan is active

Trial: None · Observed 2026-11-08 · Source page

Pages & changes

Tracked since 2026-11-06

Key pages

Weekly snapshots
annualreportai.live/ Snapshot 2026-11-08

Changes

No pricing, plan, or positioning changes detected since tracking started.

Questions & evidence

How much does Annual Reports AI cost?
Top-up packs: Unknown. Observed 2026-11-08. Check the source for current billing terms, usage limits and taxes.Source
How much website traffic does Annual Reports AI get?
Vaneform estimates <5K website visits in 2026-10. Visits can include repeat visits; this estimate measures web traffic separately from paying customers or revenue.Source
What is Annual Reports AI and what platforms does it support?
Annual Reports AI is catalogued under Financial Data & Research: Decode any business in minutes — not weeks. Supported platforms: Web.

Related products in this category

Finance / Financial Data & Research

These products share a catalog category. Compare customer tasks, features and deployment requirements before treating them as alternatives.